Excipient Talk #28 | From Identity to Functionality in Excipients | brought to you by galenIQ™!

Welcome to Excipient Talk - brought to you by galenIQ™! In this episode of Excipient Talk, Dr. Michael Black speaks with Samir Nasser‑Eddin about how the pharmaceutical excipient landscape has changed over the past decades. Drawing on more than 30 years of experience, Samir shares how formulations have evolved from simple systems to complex, performance‑driven dosage forms and why excipients today are evaluated not only for their identity but for their functionality, impact on stability, and influence on clinical outcomes. The conversation covers the increasing importance of regulatory requirements, traceability, and supply chain transparency, as well as current expectations for documentation and sustainability. Samir also reflects on real formulation challenges, titanium dioxide alternatives, and the growing role of excipients in both pharmaceutical and nutraceutical applications. Visit our website for more information: https://www.beneo.com/pharmaceutical-... Subscribe for more updates and insights from the pharmaceutical industry! 00:00 – Welcome to Excipient Talk with Dr. Michael Black & Samir Nasser‑Eddin 03:28 – First experience with galenIQ™ and multifunctionality 05:01 – Why excipients shifted from identity to functionality 07:12 – Safety incidents and stricter regulation 09:22 – Traceability and supply chain expectations today 11:25 – Sustainability potential of excipients like isomalt 12:43 – Key documentation & regulatory requests 15:21 – TiO₂ replacement challenges and solutions 17:25 – Practical formulation insights and case examples 18:43– Growth of nutraceuticals and future outlook 19:46 – Closing remarks